Evidence map›Paper›PMID 22179281›Full record

ArticleNature immunology2011

A new synthesis for antibody-mediated immunity.

Arturo Casadevall, Liise-Anne Pirofski

Abstract read
In one paragraph

Article in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. A Handle on Mass Coincidence Errors inJournal of proteome research · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. IgG3 constant region GM (γ marker) allotypes could influence the neutralizing potency of anti-SARS-CoV-2 monoclonal antibodies.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Idiosyncratic Biogenesis of Intracellular Pathogens-Containing Vacuoles.Frontiers in cellular and infection microbiology · 2021
    Review
  16. Review
  17. Article
  18. Advances in Fungal Peptide Vaccines.Journal of fungi (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arturo CasadevallArturo Casadevall and Liise-anne Pirofski are in the Department of Microbiology and Immunology and Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA. arturo.casadevall@einstein.yu.edu
Liise-Anne Pirofski

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LIPKIN, W. IAN · 2003 to 2014
$100.8M
Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
VARIABLE GENE USE AND PNEUMOCOCCAL IMMUNITY IN AIDSR01AI045459 · NIAID · YESHIVA UNIVERSITY · PI PIROFSKI, LIISE-ANNE · 2000 to 2010
$3.9M
Human Antibodies to Crytococcus NeoformansR01AI035370 · NIAID · YESHIVA UNIVERSITY · PI PIROFSKI, LIISE-ANNE · 1994 to 2009
$3.3M
VARIABLE GENE DEFECTS AND PNEUMOCOCCAL SUSCEPTIBILITYR01AI044374 · NIAID · YESHIVA UNIVERSITY · PI PIROFSKI, LIISE-ANNE · 2001 to 2010
$2.7M
NHLBI NIH HHS HL059842NHLBI NIH HHS R01 HL059842NIAID NIH HHS 5U54AI057158-08NIAID NIH HHS AI033774NIAID NIH HHS AI44374NIAID NIH HHS AI45459NIAID NIH HHS R01 AI033774NIAID NIH HHS R01 AI035370NIAID NIH HHS R01 AI044374NIAID NIH HHS R01 AI045459NIAID NIH HHS U54 AI057158
6 · The paper itself

Abstract

The view that immunoglobulins function largely by potentiating neutralization, cytotoxicity or phagocytosis is being replaced by a new synthesis whereby antibodies participate in all aspects of the immune response, from protecting the host at the earliest time of encounter with a microbe to later challenges. Perhaps the most transformative concept is that immunoglobulins manifest emergent properties, from their structure and function as individual molecules to their interactions with microbial targets and the host immune system. Given that emergent properties are neither reducible to first principles nor predictable, there is a need for new conceptual approaches for understanding antibody function and mechanisms of antibody immunity.

Indexed as

Immunity, HumoralAnimalsAntibodiesAntibody-Dependent Cell CytotoxicityAntibody FormationHumansAntibodies

Identifiers

PMID22179281
PMCPMC3589717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.